Home

Santen Pharmaceutical ADR (SNPHY)

9.8050
+0.2350 (2.46%)
OP · Last Trade: Apr 27th, 10:10 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close9.570
Open9.805
Bid-
Ask-
Day's Range9.805 - 10.18
52 Week Range8.650 - 13.00
Volume1,223
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume8,280

Chart

News & Press Releases

SNPHY Stock Earnings: Santen Pharmaceutical Reported Results for Q4 2023investorplace.com
Santen Pharmaceutical just reported results for the fourth quarter of 2023.
Via InvestorPlace · May 17, 2024
Current Analysis: Santen Pharmaceuticaltalkmarkets.com
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. Over the past year, Santen's share price rose about 32% from $7.60 to $10.01 as of Thursday’s market close
Via Talk Markets · February 15, 2024